Attached files

file filename
10-Q - Q3 10Q - Obagi Medical Products, Inc.form10q.htm
EX-10.57 - TRIAX AGREEMENT - REDACTED VERSION - Obagi Medical Products, Inc.exhibit10_57.htm
EX-10.58 - CELLOGIQUE AMMENDMENT NO 2 - REDACTED VERSION - Obagi Medical Products, Inc.exhibit10_58.htm
EX-10.48 - ROHTO AMMENDMENT - REDACTED VERSION - Obagi Medical Products, Inc.exhibit10_48.htm
EX-31.2 - 302 CERTIFICATION - Obagi Medical Products, Inc.exhibit31_22009q3.htm
EX-32.2 - 906 CERTIFICATION - Obagi Medical Products, Inc.exhibit32_22009q3.htm
EX-31.1 - 302 CERTIFICATION - Obagi Medical Products, Inc.exhibit31_12009q3.htm
Exhibit 32.1

 
Obagi Medical Products, Inc.
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Quarterly Report on Form 10-Q of Obagi Medical Products, Inc. (the "Company") for the three months ended September 30, 2009, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Steven R. Carlson, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
(1)   The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2)   The information contained in the Report fairly presents, in all material respects, the financial condition and results of   operations of the Company.

     
       
Date:  November 6, 2009
By:
/s/ STEVEN R. CARLSON
 
   
Steven R. Carlson
 
   
Chief Executive Officer
 
   
(Prinicpal Executive Officer)